Ira Lubert - Safeguard Scientifics Independent Director

SFEDelisted Stock  USD 0.46  0.19  29.23%   

Director

Mr. Ira M. Lubert is Independent Director of the Company. Ira M. Lubert has served as CoFounder and Chairman of each of LubertAdler Management Company, L.P., which advises a series of real estate funds, and Independence Capital Partners, LLC, which provides services to certain investment advisers. He is also a CoFounder of and a Partner in a series of private equity and real estate fund advisers, including LLR Management, L.P., which focuses on lower middle market growth companies Quaker Partners Management, L.P., which advises a series of life sciences funds LEM Capital, L.P., which advises a series of real estate funds invested primarily in multifamily properties LBC Credit Management, LP, which advises a series of structured finance funds and Patriot Financial Management, L.P., which advises a series of community banking funds. Mr. Lubert has also served as a CoFounder of Versa Capital Management, LLC, specializing in distressed and special situations and worked with Rubenstein Partners, L.P., an office real estate investment firm, to found its first fund, Rubenstein Properties Fund, L.P. . Previously, he was a General Partner of Rose Glen Capital Management, LP, a private equity fund. From 1986 to 1997, he was a Managing Director and CoFounder of TL Ventures, the subsequent Safeguardaffiliated family of early stage venture funds with over 1 billion of capital under management. Prior to that, he served as Chairman of the Board and President of CompuCom Systems, a microcomputer reseller. Mr. Lubert currently serves on the Board of Trustees of Pennsylvania State University, where he served as Chairman from July 2016 to July 2017. He had previously served on the Pennsylvania State University Board from 1997 to 2000 and from 2007 to 2013 since 2018.
Age 67
Tenure 6 years
Phone610-293-0600
Webhttps://www.safeguard.com
Lubert holds a B.S. from Pennsylvania State University.

Safeguard Scientifics Management Efficiency

The company has Return on Asset of (0.0778) % which means that on every $100 spent on assets, it lost $0.0778. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2938) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics' management efficiency ratios could be used to measure how well Safeguard Scientifics manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 1.68 M in debt with debt to equity (D/E) ratio of 0.04, which may show that the company is not taking advantage of profits from borrowing. Safeguard Scientifics has a current ratio of 18.08, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Safeguard Scientifics until it has trouble settling it off, either with new capital or with free cash flow. So, Safeguard Scientifics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Safeguard Scientifics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Safeguard to invest in growth at high rates of return. When we think about Safeguard Scientifics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Price BlackfordCentral Securities
66
David ShawFiera Capital
63
Nisha KumarWestern Asset High
50
Antonio MonariAzimut Holding SpA
66
David GluskinMount Logan Capital
N/A
Conrad CiccotelloTortoise Mlp Closed
60
Peter AndersonFlow Capital Corp
N/A
Wilhelm BenderEuropean Equity Closed
75
Anna BortolottiAzimut Holding SpA
59
Bruce CalvinFlow Capital Corp
51
Eldon SmithFlow Capital Corp
74
Raymond LaurinFiera Capital
N/A
Richard GoeltzCentral Europe Russia
71
Teresa NicoliniAzimut Holding SpA
65
Paolo MartiniAzimut Holding SpA
44
Sylvain BrosseauFiera Capital
N/A
Catherine BestFlow Capital Corp
61
Gerardo TribuzioAzimut Holding SpA
51
Wilhelm BenderCentral Europe Russia
74
Kenneth FroewissCentral Europe Russia
75
Robert YoungNuveen New Jersey
57
It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts. Safeguard Scientifics operates under Asset Management classification in the United States and is traded on NASDAQ Exchange. Safeguard Scientifics Common (SFE) is traded on NASDAQ Exchange in USA and employs 26 people.

Management Performance

Safeguard Scientifics Leadership Team

Elected by the shareholders, the Safeguard Scientifics' board of directors comprises two types of representatives: Safeguard Scientifics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safeguard. The board's role is to monitor Safeguard Scientifics' management team and ensure that shareholders' interests are well served. Safeguard Scientifics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safeguard Scientifics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Julie Dobson, Independent Director
Ira Lubert, Independent Director
Russell Glass, Independent Director
Matthew Barnard, Secretary Counsel
Mark Herndon, Chief Financial Officer, Senior Vice President
Mark Dow, CFO CEO
David Kille, CFO
Alex Fuiks, Associate
Maureen Morrison, Independent Director
Albert II, Sr. VP and Managing Director of Healthcare
Scott Snyder, Senior Vice President Managing Director, Chief Technology and Innovation Officer
George MacKenzie, Independent Director
Jack Messman, Independent Director
John Shave, Vice President - Business Development and Corporate Communications
Eric Salzman, Chief Restructuring Officer
Stephen Zarrilli, President CEO, Director
Jeffrey McGroarty, CFO, Senior Vice President - Finance
Mark CPA, VP CFO
John Roberts, Independent Director
Robert Rosenthal, Executive Chairman of the Board, Principal Executive Officer
Stephen Fisher, Independent Director
Andrew Lietz, Independent Chairman of the Board
Seth Zuckerman, Associate Healthcare
Brian Sisko, Executive Vice President Managing Director
Mara Aspinall, Director
Joseph Manko, Independent Director

Safeguard Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safeguard Scientifics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Safeguard Stock

If you are still planning to invest in Safeguard Scientifics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Safeguard Scientifics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings